Cargando…
Anticancer effects of valproic acid on oral squamous cell carcinoma via SUMOylation in vivo and in vitro
Aberrant histone deacetylase (HDAC) has a key role in the neoplastic process associated with the epigenetic patterns of tumor-related genes. The present study was performed to investigate the effects and determine the mechanism of action of the HDAC inhibitor, valproic acid (VPA), on the CAL27 cell...
Autores principales: | Sang, Zhijian, Sun, Yang, Ruan, Hong, Cheng, Yong, Ding, Xiaojun, Yu, Youcheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228083/ https://www.ncbi.nlm.nih.gov/pubmed/28101176 http://dx.doi.org/10.3892/etm.2016.3907 |
Ejemplares similares
-
Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression
por: Terranova-Barberio, Manuela, et al.
Publicado: (2015) -
Comparison of Anticancer Effects of Carbamazepine and Valproic Acid
por: Akbarzadeh, Ladan, et al.
Publicado: (2016) -
HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo
por: Segura-Pacheco, Blanca, et al.
Publicado: (2007) -
In Vitro and In Vivo Radiosensitizing Effect of Valproic Acid on Fractionated Irradiation
por: Chie, Eui Kyu, et al.
Publicado: (2015) -
KLF7 overexpression in human oral squamous cell carcinoma promotes migration and epithelial-mesenchymal transition
por: Ding, Xiaojun, et al.
Publicado: (2017)